Nature Communications (Sep 2022)
Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption
Abstract
CRISPR-Cas12f nucleases can be effectively packaged into AAVs for gene therapy, but a systematic evaluation of editing outcomes is lacking. Here the authors perform a comprehensive assessment of 4 Cas12f proteins and compare to Cas9 and two Cas12a proteins at a number of sites.